Challenging the Status Quo: Examining the Treatment Landscape for Resistant or Refractory CMV in Transplant Recipients

Program Overview

This symposium will help you improve your skills in managing cytomegalovirus (CMV) infection in transplant patients, including how to identify and treat refractory or drug-resistant CMV. Join our expert panel as they discuss CMV treatment guidelines after solid organ transplant (SOT) or hematopoietic cell transplant (HCT) and new therapy for refractory or drug-resistant CMV. Challenging real-world patient cases in CMV after transplantation will be presented, offering you an opportunity to test your clinical skills and learn from the experts. Do not miss it!

Attend in-person or virtually
You must be registered for ECCMID 2023 in order to attend this Integrated Symposium

ECCMID 2023 in Copenhagen


Target Audience

Infectious disease, transplantation, and internal medicine clinicians managing patients with CMV

Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Employ approved cytomegalovirus (CMV) prevention and antiviral treatment strategies in transplant patients based on safety and efficacy data
  • Identify patients with refractory or resistant CMV using antiviral resistance testing
  • Integrate key data on approved therapies for the selection of treatment for resistant or refractory CMV

Activity Faculty

Genovefa Papanicolaou, MD (Chair)

Genovefa Papanicolaou, MD (Chair)

Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor, Medicine
Weill Cornell Medical College
Cornell University
New York, NY, United States

Hans H. Hirsch, MD, MSc

Hans H. Hirsch, MD, MSc

Professor, Senior Clinical Consultant
Transplantation & Clinical Virology
University of Basel
Basel, Switzerland


Atul Humar, MD, FRCPC, FAST

Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada

Provider Statement

This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.

Supporter Statement

This activity is supported by an educational grant from Takeda.


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources